Results 1 to 10 of about 198,375 (333)

Low molecular-weight heparin is better than warfarin for prevention of recurrent venous thromboembolism in cancer patients [PDF]

, 2017
A critical appraisal and clinical application of Lee AYY, Levin MN, Bake RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003;349:146-153.
Choi, Sarah
core   +3 more sources

Low molecular weight heparin-induced thrombocytopenia management during hemodialysis and cardiac surgery: a case report and literature review [PDF]

JA Clinical Reports
Background Heparin-induced thrombocytopenia (HIT) is a serious complication of heparin therapy, including low molecular weight heparins (LMWHs) like dalteparin.
Shuto Takada, Shogo Suzuki, Takahiro Tamura   +2 more
doaj   +2 more sources

Poly(dimethylsiloxane)-poly(ethyleneoxide)-heparin block copolymers. I. Synthesis and characterization [PDF]

, 1988
Amphiphilic block copolymers containing poly(dimethylsiloxane), poly(ethylene oxide), and heparin (PDMS-PEO-Hep) have been prepared via a series of coupling reactions using functionalized prepolymers, diisocyanates, and derivatized heparins.
Agarwal, Atkinson, Bara, Barrowcliffe, Bjork, Borsch, Breuker, Carlton, Danishefsky, Danishefsky, Dumelow, Ebert, Ebert, Grainger, Hennink, Hoffman, Hughes, Kossmehl, Kossmehl, Kurzer, Lane, Lyman, Miura, Mori, Okano, Okano, Okano, Okano, Okano, Piepkorn, Plueddeman, Quast, Rich, Smith, Solomon, Tezuka, Thunberg, Torchilin, Vulic, Yamashita, Yilgor   +40 more
core   +25 more sources

Urticarial reaction to low molecular weight heparin injections. [PDF]

Obstet Med
Hill A, Williams C, Finucane K, Carson N, Neuberger F, Xie F.   +5 more
europepmc   +3 more sources

Comparing survival with vitamin K antagonists, low-molecular-weight heparin, and direct oral anticoagulants in patients with cancer-a systematic review and meta-analysis. [PDF]

Res Pract Thromb Haemost
Xirou V, Patel A, Altamirano MFA, Singh R, Gusdorf J, Barnum K, McNichol M, Ryu J, Zwicker JI, Chiasakul T, Patell R.   +10 more
europepmc   +2 more sources

LOW MOLECULAR WEIGHT HEPARINS [PDF]

Medical Journal Armed Forces India, 1998
Low-molecular-weight heparins (LMWH) are a new group of parenteral anticoagulants. They represent a major clinical advance in anticoagulation since the identification of unfractionated heparin (UFH) in 1922 and the introduction of the synthetic coumarin derivative, warfarin, in 1948.
J N, Huang, A, Shimamura
openaire   +4 more sources

Inhibition of trypsin by heparin and dalteparin, a low molecular weight heparin [PDF]

Journal of the Serbian Chemical Society, 2009
The interaction between trypsin, a prototype S1 serine protease, with heparin and its low molecular weight derivative dalteparin were investigated. Direct inhibition of the proteolytic activity of trypsin by heparin and dalteparin, used in concentrations
OLIVERA M. BOSNIĆ, KRISTINA R. GOPČEVIĆ, MIROSLAV M. VRVIĆ, IVANKA M. KARADŽIĆ   +3 more
doaj   +3 more sources

Therapeutic inefficacy of protocol driven intravenous unfractionated heparin infusion in the current era

American Heart Journal Plus, 2023
Unfractionated heparin (UFH) is commonly used for several life-threatening conditions requiring anticoagulant therapy but failure to reach therapeutic levels in 24 h can be associated with adverse outcomes.
Kayla Torppey, Marc Cohen, Manpreet Kaur, Natale Wasef, Aanchal Wats, Sumit Sohal, Gautam Visveswaran, Sandra Richardson   +7 more
doaj   +1 more source

Low molecular weight heparin in COVID-19: benefits and concerns

Frontiers in Pharmacology, 2023
Since its emergence, the COVID-19 pandemic had a dramatic impact on the public health worldwide and it scarred the medical, economical, and social determinants of health.
Adham Makarem, Adham Makarem, Rana Zareef, Joseph Abourjeili, Joseph E Nassar, Fadi Bitar, Fadi Bitar, Fadi Bitar, Mariam Arabi, Mariam Arabi, Mariam Arabi   +10 more
doaj   +1 more source

The Effect of Low Molecular Weight Heparins on Placentation: A Rat Model Study

Cumhuriyet Science Journal, 2022
Low molecular weight heparins (LMWHs) have been used for the treatment for recurrent pregnancy loss (RPL) for a long time. We aimed to investigate the efficacy of the LMWHs on angiogenesis and apoptosis during placentation.
Gülizar Özer, Çağlar Yıldız, Hatice Özer, Ali Çetin   +3 more
doaj   +1 more source